The microbiota-gut-brain axis and its great projections

被引:23
作者
Gomez-Eguilaz, Maria [1 ]
Ramon-Trapero, Jose L. [2 ]
Perez-Martinez, Laura [3 ]
Blanco, Jose R. [4 ]
机构
[1] Hosp San Pedro, Secc Neurol, Piqueras 98, E-26006 Logrono, La Rioja, Spain
[2] Ctr Salud Siete Infantes Lara, Logrono, La Rioja, Spain
[3] CIBIR, Ctr Invest Biomed La Rioja, Enfermedades Infecciosas, Logrono, La Rioja, Spain
[4] Hosp San Pedro, CIBIR, Dept Enfermedades Infecciosas, Logrono, La Rioja, Spain
关键词
Alzheimer's disease; Epilepsy; Gut-brain axis; Microbiota; Multiple sclerosis; Parkinson's disease; INTESTINAL MICROBIOTA; HEALTH; BEHAVIOR; STRESS; DISORDERS; SYSTEM; MOUSE;
D O I
10.33588/rn.6803.2018223
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction. The microbiota is the set of millions of microorganisms that coexist in a symbiotic way in our body. It is mainly located in the digestive tract, being distributed in function of the chemical properties and the functions of the different organs. The factors that influence its composition are multiple (diet, individual habits, diseases or drugs). It also participates in several functions of the organism such as metabolism, immunity or even the function of the central nervous system. Development. This last interrelationship is called: gut-brain axis. For years the relationship between the microbiota and the central nervous system has been known and how they influence one over the other. It is postulated that communication occurs through three systems: the vagus nerve, the systemic pathway (with the release of hormones, metabolites and neurotransmitters) and the immune system (by the action of cytokines). Conclusions. There are still many unknowns to be clarified in this field, but this microbiota-intestine-brain relationship is postulated as a possible pathogenic basis for neurological diseases of great health impact such as Alzheimer, Parkinson or multiple sclerosis. There are currently studies with probiotics with hopeful results in patients with Alzheimer's disease.
引用
收藏
页码:111 / 117
页数:7
相关论文
共 49 条
[31]   The Human Intestinal Microbiome in Health and Disease [J].
Lynch, Susan V. ;
Pedersen, Oluf .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (24) :2369-2379
[32]  
Malkki H, 2017, NAT REV NEUROL, V13, P5, DOI [10.1038/nrneurol.2016.170, 10.1038/nrneurol.2016.195]
[33]   One more role for the gut: microbiota and blood brain barrier [J].
Michel, Laure ;
Prat, Alexandre .
ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (01)
[34]   The Gut Microbiome in Multiple Sclerosis [J].
Mielcarz, Daniel W. ;
Kasper, Lloyd H. .
CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2015, 17 (04)
[35]   Nitrosative Stress, Hypernitrosylation, and Autoimmune Responses to Nitrosylated Proteins: New Pathways in Neuroprogressive Disorders Including Depression and Chronic Fatigue Syndrome [J].
Morris, Gerwyn ;
Berk, Michael ;
Klein, Hans ;
Walder, Ken ;
Galecki, Piotr ;
Maes, Michael .
MOLECULAR NEUROBIOLOGY, 2017, 54 (06) :4271-4291
[36]   Microbial endocrinology: the interplay between the microbiota and the endocrine system [J].
Neuman, Hadar ;
Debelius, Justine W. ;
Knight, Rob ;
Koren, Omry .
FEMS MICROBIOLOGY REVIEWS, 2015, 39 (04) :509-521
[37]   Obesity pandemics and the modification of digestive bacterial flora [J].
Raoult, D. .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2008, 27 (08) :631-634
[38]  
Richarte V, 2018, REV NEUROLOGIA, V66, pS109
[39]   Control of Brain Development, Function, and Behavior by the Microbiome [J].
Sampson, Timothy R. ;
Mazmanian, Sarkis K. .
CELL HOST & MICROBE, 2015, 17 (05) :565-576
[40]   Specialized Metabolites from the Microbiome in Health and Disease [J].
Sharon, Gil ;
Garg, Neha ;
Debelius, Justine ;
Knight, Rob ;
Dorrestein, Pieter C. ;
Mazmanian, Sarkis K. .
CELL METABOLISM, 2014, 20 (05) :719-730